Accession Number: | 0001593968-19-001632 |
Date: | 2019-07-16 |
Issuer: | APTEVO THERAPEUTICS INC. (APVO) |
Original Submission Date: |
EL-HIBRI FUAD
2401 4TH AVENUE
SUITE 1050
SEATTLE, WA 98121
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-07-16 | P | 11,375 | a | $0.85 | 869,521 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the purchase price of $0.8494 is reflective of the weighted average purchase price. the prices for the transactions reported on this line range from $0.84 to $0.85. mr. el-hibri undertakes to provide, upon request by the staff of the securities and exchange commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |